Ординатура / Офтальмология / Английские материалы / Neuro-Ophthalmology_Kidd, Newman, Biousse_2008
.pdf13 Acquired Ocular Motility Disorders and Nystagmus |
321 |
Sixth Nerve Palsy (Abducens Nerve)
Cranial nerve VI innervates the lateral rectus. A sixth nerve palsy results in paresis of abduction of the ipsilateral eye and esotropia. The amount of esotropia is greatest in the direction of action of the weak muscle. The patient usually com-
plains of binocular horizontal diplopia.
As the nerve passes through Dorello’s canal,50,51 it is prone to become affected, often bilaterally, by elevations in intracranial pressure. Relatively minor head trauma may result in sixth nerve dysfunction.48 MG and restrictive medial rectus involvement in thyroid eye disease often mimic the sign of a sixth nerve palsy.
Investigation of Cranial Neuropathy Causing Diplopia
Intracranial magnetic resonance angiography (MRA) or CT angiogram (CTA) is commonly obtained to evaluate for an intracranial aneurysm in the setting, for example, of an acute onset, pupil-involving third nerve palsy. Ninety-two percent of posterior communicating artery aneurysms causing third nerve palsies are larger than 5 mm.52 MRI detects aneurysms larger than 5 mm with 97% sen-
sitivity and aneurysms smaller than 5 mm with 54% sensitivity. The rupture risk of an aneurysm less than 10 mm is 0.05% per year.53,54 Approximately 1.5%
of third nerve palsy-causing aneurysms that eventually rupture may not be detected by MRA. It is often prudent to proceed with conventional intracranial angiogram to exclude an aneurysm definitively if MRA or CTA are equivocal. Gadolinium-enhanced MRI with high resolution, thin cuts through the brainstem increases diagnostic yield, especially after an aneurysm is excluded by MRA or CTA. If MRI is unremarkable, lumbar puncture may be required to assess for cerebrospinal fluid abnormalities. Acute onset of a painful, pupilsparing third nerve palsy and sixth nerve palsy may represent microvascular ischemia to the nerve, especially in older patients with vascular risk factors.55 Spontaneous resolution over 8 to 12 weeks is typical. Investigation of the other causes noted in the table should also be undertaken.
Multiple Cranial Neuropathies
Lesions at the cavernous sinus are associated with third, fourth, and sixth nerve pareses in combination with signs of involvement of the first and second divisions of the trigeminal nerve and sympathetic fibers. Primary tumors such as parasellar meningiomas, lymphoma, and pituitary adenomas and secondary tumors including nasopharyngeal carcinoma and myeloma; vascular disorders such as carotid-cavernous fistula and intracavernous internal carotid artery aneurysm; and inflammatory disorders such as Tolosa Hunt syndrome, Wegener’s granulomatosis, Rosai-Dorfman syndrome, and hypertrophic pachymeningitis may all cause cavernous sinus syndromes (Table 13-1). Lesions at the orbital apex may affect the oculomotor, trochlear, and abducens nerves in combination with the first division of the trigeminal nerve and the optic nerve. Proptosis, chemosis, and conjunctival injection are often present. Inflammation, including orbital pseudotumor and those noted previously, infection from the sphenoid and ethmoid sinuses, particularly aspergillosis and mucormycosis, and primary and secondary neoplastic disease may all cause orbital apex syndromes.
322 |
Neuro-Ophthalmology: Blue Books of Neurology |
|
|
TABLE 13-1 Causes of Third, Fourth, and Sixth Cranial Nerve Paresis
|
Site |
Disorder |
|
|
|
|
|
|
Brainstem |
Infarction |
|
|
|
Hemorrhage |
|
|
|
Demyelination |
|
|
|
Tumor |
|
|
|
Infection/abscess |
|
|
Subarachnoid |
Aneurysm |
|
|
course |
Meningitis, including carcinomatous and leukemic infiltration, |
|
|
|
infectious including bacteria, spirochetes, and aseptic |
|
|
|
meningitis |
|
|
|
Microvascular infarction |
|
|
|
Tumor |
|
|
Cavernous sinus/ |
Internal carotid aneurysm |
|
|
orbital apex |
Caroticocavernous fistula |
|
|
|
Pituitary lesions |
|
|
|
Meningioma |
|
|
|
Metastasis |
|
|
|
Microvascular |
|
|
|
Sphenoid and ethmoid mucoceles |
|
|
|
Tolosa-Hunt syndrome, Wegener’s granulomatosis and other |
|
|
|
inflammatory disorders |
|
|
|
Herpes zoster |
|
|
Orbit |
Trauma |
|
|
|
Infections |
|
|
|
Tumor |
|
|
|
|
|
Multiple ocular motor nerves may be affected in Guillain-Barre´ syndrome or in the Miller-Fisher variant of Guillain-Barre´. The classic triad of Miller-Fisher syndrome is ophthalmoplegia, ataxia, and areflexia. In addition to ophthalmoplegia, pupillary light-near dissociation is common. Anti-GQ1b antibodies are present in greater than 90% of patients with Miller-Fisher syndrome and are associated with Campylobacter jejuni infections. Treatment if required is with plasma exchange or intravenous immunoglobulin, as for Guillain-Barre´ syndrome
BRAINSTEM DISORDERS
Cranial Nerve Nuclei
As has been noted in Chapter 1, nuclear lesions differ in clinical appearance from their corresponding cranial neuropathies. A third nerve nuclear lesion causes bilateral impairment of ocular elevation (resulting from contralateral innervation of the superior rectus) and bilateral ptosis (resulting from a single midline levator palpebrae subnucleus that innervates both levator muscles).56,57 Very rarely, a third nerve nuclear lesion may result in isolated weakness of a single muscle such as the inferior or superior rectus.58,59
A fourth nerve nuclear lesion causes a superior oblique palsy clinically similar to a fourth nerve lesion; however, the superior oblique weakness is contralateral to
13 Acquired Ocular Motility Disorders and Nystagmus |
323 |
the nuclear lesion because of the fourth nerve decussation after dorsal emergence from the midbrain. In addition, a fourth nerve nuclear lesion is almost invariably accompanied by a Horner’s syndrome ipsilateral to the lesion because of the proximity of the preganglionic sympathetic fibers to the dorsally placed fourth nerve nucleus.60
A sixth nerve nuclear lesion causes an ipsilateral horizontal gaze palsy.61–63 Although rare cases of isolated horizontal gaze palsy are reported,63 it is nearly always accompanied by an ipsilateral seventh cranial nerve palsy with lower motor neuron facial weakness (because of the anatomic proximity of the seventh cranial nerve fascicle to the sixth nerve nucleus, which it wraps around).
SUPRANUCLEAR OCULAR MOTILITY CONTROL
Supranuclear eye movement abnormalities result from dysfunctional cerebral, cerebellar, and brainstem afferent connections to the ocular motor cranial nerve nuclei. Because of the excessive demands that saccadic eye movements place on the neural network, a clinical hallmark of supranuclear eye movement disorders is disproportionate involvement of saccadic eye movements relative to smooth pursuit. Vestibular eye movements are typically intact. In contrast, a nuclear or infranuclear process impairs saccades, smooth pursuit, and vestibular eye movements to the same extent.
Burst neurons in the brainstem provide the sudden, intense neural discharge required to initiate a high velocity saccade and to overcome dampening, orbital elastic forces. Burst neurons for horizontal saccades are located in the paramedian pontine reticular formation (PPRF) and, for vertical saccades, in the rostral interstitial medial longitudinal fasciculus (riMLF) in the midbrain (Chapter 1). A lesion of the PPRF causes slow or absent horizontal saccades and a lesion of the riMLF causes slow or absent vertical saccades. Burst neurons must be inhibited; otherwise constant saccades would occur and disrupt vision. This is provided to both the horizontal and vertical burst neurons by omnipause neurons located in the pons. Dysfunction of these neurons results in excessive back-to-back saccades in either the horizontal directions (ocular flutter) or in all directions (opsoclonus) (see later).
The dorsal midbrain syndrome is comprised of a supranuclear upgaze palsy, convergence-retraction nystagmus, lid retraction (Collier’s sign), and pupillary light-near dissociation. The most common etiologies are a pineal gland cyst or hemorrhage and hydrocephalus. A supranuclear upgaze palsy with forced downward deviation of the eyes (“peering at the tip of the nose”) may result from a thalamic lesion that extends into the midbrain.64 Thalamic esotropia, in which the eyes are deviated medially on both sides, arises because of excessive convergence tone with compression or involvement of the dorsal midbrain.65
Gaze deviation is a common manifestation of a supranuclear disorder. The frontal eye fields (FEF) project to the contralateral PPRF; a destructive lesion of the FEF, for example, following cerebral infarction, results in ipsiversive bilateral gaze deviation; the patient “looks at the lesion.” With an irritative lesion, for example, seizure or hemorrhage, there is contraversive deviation; the patient “looks away from the lesion.” A thalamic lesion, however, may cause “wrong way eyes” in which the patient “looks away” from a destructive lesion.66
Degenerative brainstem diseases such as progressive supranuclear palsy, Parkinson’s disease, spinocerebellar degenerations, and Huntington’s disease
324 |
Neuro-Ophthalmology: Blue Books of Neurology |
|
|
and metabolic disorders such as Wilson’s disease and lipid storage diseases may all show distinctive abnormalities of supranuclear ocular motility control.
Internuclear ophthalmoparesis (INO) results from a lesion of the medial longitudinal fasciculus (MLF), which carries signals from the abducens nucleus to the contralateral medial rectus subnucleus of the oculomotor nucleus. These signals allow conjugate horizontal eye movements with co-contraction of the ipsilateral lateral rectus and contralateral medial rectus muscles. A unilateral INO leads to impaired adduction of the eye ipsilateral to the MLF lesion and dissociated nystagmus of the contralateral abducting eye. Despite adduction weakness on direct horizontal motility testing, adduction of the eye ipsilateral to the MLF lesion is intact with convergence eye movements because direct vergence signals to the medial rectus motor neurons do not pass through the MLF.67 The eye movements may appear normal with bedside smooth pursuit testing and the presence of an INO diagnosed only by the identification of a decreased velocity of the adducting eye compared with the abducting eye during saccadic testing, known as adduction lag.68 Multiple sclerosis; vascular lesions such as infarction, hemor-
rhage, and arteriovenous malformations; and tumors are the most common causes of INO.69,70 Bilateral INO is usually because of multiple sclerosis and may be
associated with a marked exotropia; the “walled eyed” bilateral INO.
Because the PPRF and MLF lie in close proximity within the brainstem on each side, lesions in this region may affect both structures, leading to the “one and a half syndrome” coined by Miller-Fisher. The coexistence of an INO and an ipsilateral horizontal gaze palsy results in there being only abduction in the contralateral eye and no other horizontal eye movement.
Skew deviation is a vertical misalignment of the visual axes. Patients have a hypertropia, which may be concomitant (the same in all directions of gaze), or incomitant. It may be difficult to differentiate incomitant skews from other ocular motility problems such as ophthalmoparesis because of dysfunction of cranial nerves III or IV, but there should be other signs of brainstem or cerebellar dysfunction. It occurs when a disorder causes a mismatch between inputs to the brainstem from the otoliths on both sides.
Some patients may have an INO as well. Others may show the ocular tilt reaction (OTR), in which there is a tilt of the head to the side contralateral to the lesion. It is assumed that this reflects a compensation by the brainstem for the loss of vestibular input; the patient’s position of center of gravity has been shifted. The OTR may be paroxysmal or sustained. Skew deviation with or without the OTR may arise with lesions in the cerebellum, midbrain (particularly lesions of the dorsal midbrain which include the interstitial nucleus of Cahal), and pons.
Abnormal Spontaneous Eye Movements
NYSTAGMUS
Nystagmus is a repetitive to-and-fro movement of the eyes that can be congenital or acquired, physiologic or pathologic. Physiologic nystagmus is sometimes evident at a bedside motility examination and consists of low-amplitude, high-frequency gaze-evoked nystagmus present only in extremes of horizontal gaze. The nystagmus will resolve when the eyes are moved to a slightly less eccentric gaze position.
13 Acquired Ocular Motility Disorders and Nystagmus |
325 |
Pathologic acquired nystagmus is described as jerk or pendular; jerk nystagmus is characterized by a to-and-fro oscillation whose phases are of unequal velocity, termed the slow and fast phases, whereas in pendular nystagmus the phases have equal velocity. Although the direction of jerk nystagmus is named after the direction of the fast phase, the underlying mechanism generating the abnormal eye movement is the slow phase, or slow drift of the eyes away from the desired position. The fast phase is a rapid, corrective movement in the opposite direction. There are three primary mechanisms by which an image is maintained on the fovea: fixation, the vestibulo-ocular reflex, and eccentric gaze holding. Nystagmus may result from disruption of any one of these mechanisms.
Nystagmus Associated with Visual Loss
Visual loss of any cause may disrupt fixation and be associated with nystagmus; that resulting from optic nerve disease is more commonly pendular and that resulting from retinal disease more commonly of jerk type. In the Heimann-
Bielchowsky phenomenon, the nystagmus is more prominent in the eye with the greater visual loss71–74 or may arise when the visual loss is only in one
eye. This is usually pendular and is more prominent in the vertical direction.
Acquired Pendular Nystagmus
Acquired pendular nystagmus (APN) is one of the most visually disabling types of nystagmus. It is a pendular nystagmus that may have horizontal, vertical, or torsional components. APN may occur in the setting of visual loss because of optic neuritis, but it is more commonly seen in brainstem lesions, for example, because of multiple sclerosis;75 Pelizaeus-Merzbacher disease; lysosomal storage diseases; brainstem infarction; Whipple’s disease76 (when it is associated with oculomasticatory myorhythmia); spinocerebellar degenerations; toluene abuse;77 or as a component of oculopalatal myoclonus (oculopalatal tremor),78 in which pendular nystagmus with a prominent vertical component associated with a synchronous palatal tremor develops months after brainstem or cerebellar infarction. Others brainstem signs are invariably present, such as INO and skew deviation.
Treatment of APN
A double-blind, placebo-controlled, cross-over study comparing gabapentin and baclofen found gabapentin to be highly effective in minimizing oscillopsia and ocular oscillations in patients with APN.79 The known role of gammaaminobutyric acid (GABA)-ergic neural transmission in control of the neural integrator, which functions to maintain stability of the eyes in eccentric gaze positions, suggests altered GABA transmission as a mechanism for APN. Memantine, clonazepam, valproate, and scopolamine may also be tried.80,81 Patients with oculopalatal tremor may respond to carbamazepine.82,83
Nystagmus from Vestibular Imbalance
Nystagmus from vestibular imbalance may be caused by disease of peripheral or central vestibular pathways. With peripheral vestibular disease, asymmetric vestibular inputs result in jerk nystagmus because the unaffected and unopposed
326 |
Neuro-Ophthalmology: Blue Books of Neurology |
|
|
contralateral vestibular nucleus drives the eyes slowly toward the side of the lesion, and hence the direction of the nystagmus is away from the lesion. An important feature of peripheral vestibular nystagmus is that it is accentuated by, and indeed may only be detected with, elimination of fixation, for example, with Frenzel goggles. The nystagmus is usually of mixed torsional and horizontal direction. Most nystagmus from acute peripheral vestibular impairment such as benign paroxysmal positional vertigo or acute labyrinthitis resolves spontaneously; however, if oscillopsia or vertigo are significantly debilitating, acute management with pharmacologic agents such as diphenhydramine or promethazine may be beneficial.
Imbalance of central vestibular connections may result in vertical or torsional nystagmus. Elimination of fixation tends not to influence the severity of the nystagmus appreciably. Downbeat nystagmus, in which the slow phase is in an upward direction and which is accentuated looking down and to either side, may arise because calcium channel-rich cerebellar Purkinje cells inhibit the vestibular nucleus mediating downward, but not upward, eye movements. This causes a relative decrease in inhibition of upward eye movements, with a resultant slow drifting of the eyes upward and fast corrective downward eye movements.84 Other signs of cerebellar dysfunction, such as abnormal vestibulo-ocular reflex, are also seen.
Upbeat nystagmus is usually present in the primary position of gaze and, like downbeat nystagmus, increases when the eye is moved in the direction of the nystagmus. It is not, however, accentuated by looking to either side. Vertical nystagmus is almost always associated with a central cause, although a peripheral vestibular lesion can occasionally be associated with upbeating nystagmus, usually with a torsional component.
Either downbeat or upbeat nystagmus may result from a variety of other brainstem or cerebellar pathologies such as vascular disorders, tumors, encephalitis, inherited and acquired causes of cerebellar degeneration, multiple sclerosis and other inflammatory diseases, and metabolic states such as drug intoxication with lithium and anticonvulsants, Wernicke’s encephalopathy, and vitamin B12 deficiency. Downbeat nystagmus may also be caused by structural lesions of the craniocervical junction, such as Arnold-Chiari malformation (Fig. 13–8),85 Paget’s disease and basilar invagination, and foramen magnum lesions such as meningioma. Pure torsional nystagmus is rare and is associated with the brainstem diseases noted previously.
Treatment
The potassium channel blockers 3,4-diaminopyridine and 4 aminopyridine
are effective treatments for downbeat nystagmus.86,87 Clonazepam, baclofen, and gabapentin may also be useful.88,89
Periodic Alternating Nystagmus
Periodic alternating nystagmus (PAN) is a horizontal jerk nystagmus that spontaneously reverses direction every 60 to 90 seconds. It is often missed if the examiner does not watch the eyes for long enough. At the time of direction-reversal, there may be a transition period in which vertical nystagmus or a series of square wave jerks may arise, before the horizontal nystagmus changes direction and
13 Acquired Ocular Motility Disorders and Nystagmus |
327 |
Figure 13–8 Sagittal T1-weighted magnetic resonance imaging with gadolinium showing an ArnoldChiari type I malformation.
continues. It may occur in multiple sclerosis, cerebellar degenerations or mass lesions, brainstem infarction, anticonvulsant toxicity, meningoencephalitis, and trauma. In an animal model, PAN results from ablation of the cerebellar nodulus and uvula, structures known to use GABA B inhibitory pathways to control rotationally induced nystagmus.90 Both experimental and clinical PAN respond well to the GABA B agonist baclofen.91
Seesaw Nystagmus
This is a rare nystagmus in which one eye elevates and intorts while the other moves down and extorts, then the movement reverses. It occurs in patients with chiasmal visual loss due, for example, to pituitary and other parasellar lesions but may also arise in brainstem lesions that involve the interstitial nucleus of Cahal in the midbrain. Treatment of the parasellar lesion usually improves the condition, as do baclofen, clonazepam, and alcohol.
Gaze-Evoked Nystagmus
Gaze-evoked nystagmus is the most common type of nystagmus, is absent in central position, and beats in the direction of eccentric gaze. It is the result of impairment in eccentric gaze holding mechanisms from a variety of causes, including anticonvulsant or sedative medications and brainstem lesions that have impaired the function of the diffuse gaze-holding neural network. Because it is absent in central position, it is generally not visually disabling and, therefore, does not require treatment.
SACCADIC INTRUSIONS
In contrast to nystagmus, in which the initial abnormal movement is a slow drift of the eyes away from their desired position, the initial abnormal eye movement
328 |
Neuro-Ophthalmology: Blue Books of Neurology |
|
|
with saccadic intrusions is a sudden saccadic movement that abolishes steady fixation. The spectrum of saccadic intrusions ranges from abnormal intrusive single saccades (macrosquare wave jerks) to sustained saccadic oscillations (ocular flutter and opsoclonus). Back-to-back saccades with no saccadic interval in the horizontal plane are termed ocular flutter, whereas similar saccadic intrusions in all directions are termed opsoclonus. Ocular flutter and opsoclonus arise because of disease of pontine omnipause neurons that normally inhibit saccadic burst neurons.92 Many causes of ocular flutter and opsoclonus, such as viral parainfectious encephalitis, meningitis, and medication toxicity, resolve spontaneously. Others, such as paraneoplastic syndromes, stroke, or tumor, may not and clonazepam or gabapentin may be tried but are not very effective.
REFERENCES
1.Carpenter R: The visual origins of ocular motility. In Carpenter R (eds): Eye Movements. London, MacMillan Press, 1991, pp 1–10.
2.Hirst LW, Miller NR, Johnson RT: Monocular polyopia. Arch Neurol 1983;40:756–757.
3. Coffeen P, Guyton DL: Monocular diplopia accompanying ordinary refractive errors. Am J Ophthalmol 1988;105:451–459.
4.Garcia Medina JJ, Garcia Medina M, Pinazo Duran MD, Morales Suarez-Varela M: Monocular diplopia after neodymium: YAG laser capsulotomy. Graefes Arch Clin Exp Ophthalmol 2005;243:1288–1290.
5.Rucker JC, Tomsak RL: Binocular diplopia. A practical approach. Neurologist 2005;11:98–110.
6.Trillenberg P, Zee DS: On the distribution of fast-phase intervals in optokinetic and vestibular nystagmus. Biol Cybern 2002;87:68–78.
7.Cremer PD, Halmagyi GM, Aw ST, et al: Semicircular canal plane head impulses detect absent function of individual semicircular canals. Brain 1998;121(pt 4):699–716.
8.Halmagyi GM, Curthoys IS: A clinical sign of canal paresis. Arch Neurol 1988;45:737–739.
9.Black RA, Halmagyi GM, Thurtell MJ, et al: The active head-impulse test in unilateral peripheral vestibulopathy. Arch Neurol 2005;62:290–293.
10.Leigh RJ, Kennard C: Using saccades as a research tool in the clinical neurosciences. Brain 2004;127:460–477.
11.Goh SY, Ho SC, Seah LL, et al: Thyroid autoantibody profiles in ophthalmic dominant and thyroid dominant Graves’ disease differ and suggest ophthalmopathy is a multiantigenic disease. Clin Endocrinol (Oxf) 2004;60:600–607.
12.Kazuo K, Fujikado T, Ohmi G, et al: Value of thyroid stimulating antibody in the diagnosis of thyroid associated ophthalmopathy of euthyroid patients. Br J Ophthalmol 1997;81:1080–1083.
13.Khoo DH, Eng PH, Ho SC, et al: Graves’ ophthalmopathy in the absence of elevated free thyroxine and triiodothyronine levels: Prevalence, natural history, and thyrotropin receptor antibody levels. Thyroid 2000;10:1093–1100.
14.Eckstein A, Quadbeck B, Mueller G, et al: Impact of smoking on the response to treatment of thyroid associated ophthalmopathy. Br J Ophthalmol 2003;87:773–776.
15.Prummel MF, Wiersinga WM: Smoking and risk of Graves’ disease. JAMA 1993;269:479–482.
16.Yuen SJ, Rubin PA: Idiopathic orbital inflammation: Distribution, clinical features, and treatment outcome. Arch Ophthalmol 2003;121:491–499.
17.Shields JA, Shields CL, Scartozzi R: Survey of 1264 patients with orbital tumors and simulating lesions: The 2002 Montgomery Lecture, part 1. Ophthalmology 2004;111:997–1008.
18.Cogan DG: Myasthenia gravis: A review of the disease and a description of lid twitch as a characteristic sign. Arch Ophthalmol 1965;74:217–221.
19.Osher RH, Griggs RC: Orbicularis fatigue: The ‘peek’ sign of myasthenia gravis. Arch Ophthalmol 1979;97:677–679.
20.Gorelick PB, Rosenberg M, Pagano RJ: Enhanced ptosis in myasthenia gravis. Arch Neurol 1981;38:531.
21.Pascuzzi RM: The edrophonium test. Semin Neurol 2003;23:83–88.
22.Beekman R, Kuks JB, Oosterhuis HJ: Myasthenia gravis: Diagnosis and follow-up of 100 consecutive patients. J Neurol 1997;244:112–118.
13 Acquired Ocular Motility Disorders and Nystagmus |
329 |
23.Phillips LH 2nd, Melnick PA: Diagnosis of myasthenia gravis in the 1990s. Semin Neurol 1990;10:62–69.
24.Ing EB, Ing SY, Ing T, Ramocki JA: The complication rate of edrophonium testing for suspected myasthenia gravis. Can J Ophthalmol 2000;35:141–144discussion 145.
25.Kupersmith MJ, Latkany R, Homel P: Development of generalized disease at 2 years in patients with ocular myasthenia gravis. Arch Neurol 2003;60:243–248.
26.Sethi KD, Rivner MH, Swift TR: Ice pack test for myasthenia gravis. Neurology 1987;37: 1383–1385.
27.Golnik KC, Pena R, Lee AG, Eggenberger ER: An ice test for the diagnosis of myasthenia gravis. Ophthalmology 1999;106:1282–1286.
28.Howard FM Jr, Lennon VA, Finley J, et al: Clinical correlations of antibodies that bind, block, or modulate human acetylcholine receptors in myasthenia gravis. Ann N Y Acad Sci 1987;505:526–538.
29.Hanisch F, Eger K, Zierz S: MuSK-antibody positive pure ocular myasthenia gravis. J Neurol 2006;253:659–660.
30.McConville J, Farrugia ME, Beeson D, et al: Detection and characterization of MuSK antibodies in seronegative myasthenia gravis. Ann Neurol 2004;55:580–584.
31.Bennett DL, Mills KR, Riordan-Eva P, et al: Anti-MuSK antibodies in a case of ocular myasthenia gravis. J Neurol Neurosurg Psychiatry 2006;77:564–565.
32.Caress JB, Hunt CH, Batish SD: Anti-MuSK myasthenia gravis presenting with purely ocular findings. Arch Neurol 2005;62:1002–1003.
33.Padua L, Stalberg E, LoMonaco M, et al: SFEMG in ocular myasthenia gravis diagnosis. Clin Neurophysiol 2000;111:1203–1207.
34.Schneider-Gold C, Gajdos P, Toyka KV, Hohlfeld RR: Corticosteroids for myasthenia gravis. Cochrane Database Syst Rev 2005CD002828.
35.Schneider-Gold C, Hartung HP, Gold R: Mycophenolate mofetil and tacrolimus: New therapeutic options in neuroimmunological diseases. Muscle Nerve 2006;34:284–291.
36.Kupersmith MJ, Ying G: Ocular motor dysfunction and ptosis in ocular myasthenia gravis: Effects of treatment. Br J Ophthalmol 2005;89:1330–1334.
37.Wirtz PW, de Keizer RJ, de Visser M, et al: Tonic pupils in Lambert-Eaton myasthenic syndrome. Muscle Nerve 2001;24:444–445.
38.Natori Y, Rhoton AL Jr: Microsurgical anatomy of the superior orbital fissure. Neurosurgery 1995;36:762–775.
39.Ksiazek SM, Slamovits TL, Rosen CE, et al: Fascicular arrangement in partial oculomotor paresis. Am J Ophthalmol 1994;118:97–103.
40.Dubuisson AS, Beckers A, Stevenaert A: Classical pituitary tumor apoplexy: Clinical features, management and outcomes in a series of 24 patients. Clin Neurol Neurosurg 2007;109:63–70.
41.Walter KA, Newman NJ, Lessell S: Oculomotor palsy from minor head trauma: Initial sign of intracranial aneurysm. Neurology 1994;44:148–150.
42.Levy RL, Geist CE, Miller NR: Isolated oculomotor palsy following minor head trauma. Neurology 2005;65:169.
43.Sebag J, Sadun AA: Aberrant regeneration of the third nerve following orbital trauma. Synkinesis of the iris sphincter. Arch Neurol 1983;40:762–764.
44.Boghen D, Chartrand JP, Laflamme P, et al: Primary aberrant third nerve regeneration. Ann Neurol 1979;6:415–418.
45.Schatz NJ, Savino PJ, Corbett JJ: Primary aberrant oculomotor regeneration. A sign of intracavernous meningioma. Arch Neurol 1977;34:29–32.
46.Cox TA, Wurster JB, Godfrey WA: Primary aberrant oculomotor regeneration due to intracranial aneurysm. Arch Neurol 1979;36:570–571.
47.Carrasco JR, Savino PJ, Bilyk JR: Primary aberrant oculomotor nerve regeneration from a posterior communicating artery aneurysm. Arch Ophthalmol 2002;120:663–665.
48.Dhaliwal A, West AL, Trobe JD, Musch DC: Third, fourth, and sixth cranial nerve palsies following closed head injury. J Neuro-ophthalmol 2006;26:4–10.
49.Feinberg AS, Newman NJ: Schwannoma in patients with isolated unilateral trochlear nerve palsy. Am J Ophthalmol 1999;127:183–188.
50.Ono K, Arai H, Endo T, et al: Detailed MR imaging anatomy of the abducent nerve: Evagination of CSF into Dorello canal. AJNR Am J Neuroradiol 2004;25:623–626.
51.Hanson RA, Ghosh S, Gonzalez-Gomez I, et al: Abducens length and vulnerability? Neurology 2004;62:33–36.
330Neuro-Ophthalmology: Blue Books of Neurology
52.Jacobson DM, Trobe JD: The emerging role of magnetic resonance angiography in the management of patients with third cranial nerve palsy. Am J Ophthalmol 1999;128:94–96.
53.Unruptured intracranial aneurysms—risk of rupture and risks of surgical intervention: International Study of Unruptured Intracranial Aneurysms Investigators. N Engl J Med 1998;339:1725–1733.
54.Chang HS: Simulation of the natural history of cerebral aneurysms based on data from the International Study of Unruptured Intracranial Aneurysms. J Neurosurg 2006;104:188–194.
55.Chou KL, Galetta SL, Liu GT, et al: Acute ocular motor mononeuropathies: Prospective study of the roles of neuroimaging and clinical assessment. J Neurol Sci 2004;219:35–39.
56.Liu GT, Carrazana EJ, Charness ME: Unilateral oculomotor palsy and bilateral ptosis from paramedian midbrain infarction. Arch Neurol 1991;48:983–986.
57.Kwon JH, Kwon SU, Ahn HS, et al: Isolated superior rectus palsy due to contralateral midbrain infarction. Arch Neurol 2003;60:1633–1635.
58.Chou TM, Demer JL: Isolated inferior rectus palsy caused by a metastasis to the oculomotor nucleus. Am J Ophthalmol 1998;126:737–740.
59.Hirose G, Furui K, Yoshioka A, Sakai K: Unilateral conjugate gaze palsy due to a lesion of the abducens nucleus. Clinical and neuroradiological correlations. J Clin Neuroophthalmol 1993;13:54–58.
60.Guy J, Day AL, Mickle JP, Schatz NJ: Contralateral trochlear nerve paresis and ipsilateral Horner’s syndrome. Am J Ophthalmol 1989;107:73–76.
61.Muri RM, Chermann JF, Cohen L, et al: Ocular motor consequences of damage to the abducens nucleus area in humans. J Neuro-ophthalmol 1996;16:191–195.
62.Tan E, Kansu T: Bilateral horizontal gaze palsy in multiple sclerosis. J Clin Neuro-ophthalmol 1990;10:124–126.
63.Miller NR, Biousse V, Hwang T, et al: Isolated acquired unilateral horizontal gaze paresis from a putative lesion of the abducens nucleus. J Neuro-ophthalmol 2002;22:204–207.
64.Choi KD, Jung DS, Kim JS: Specificity of “peering at the tip of the nose” for a diagnosis of thalamic hemorrhage. Arch Neurol 2004;61:417–422.
65.Gomez CR, Gomez SM, Selhorst JB: Acute thalamic esotropia. Neurology 1988;38:1759–1762.
66.Messe SR, Cucchiara BL: Wrong-way eyes with thalamic hemorrhage. Neurology 2003;60:1524.
67.Gamlin PD, Gnadt JW, Mays LE: Lidocaine-induced unilateral internuclear ophthalmoplegia: Effects on convergence and conjugate eye movements. J Neurophysiol 1989;62:82–95.
68.Crane TB, Yee RD, Baloh RW, Hepler RS: Analysis of characteristic eye movement abnormalities in internuclear ophthalmoplegia. Arch Ophthalmol 1983;101:206–210.
69.Muri RM, Meienberg O: The clinical spectrum of internuclear ophthalmoplegia in multiple sclerosis. Arch Neurol 1985;42:851–855.
70.Kim JS: Internuclear ophthalmoplegia as an isolated or predominant symptom of brainstem infarction. Neurology 2004;62:1491–1496.
71.Sampangi R, Chaudhuri Z, Menon V, Saxena R: Cone-rod dystrophy and acquired dissociated vertical nystagmus. J Pediatr Ophthalmol Strabismus 2005;42:114–116.
72.Leigh RJ, Zee DS: Eye movements of the blind. Invest Ophthalmol Vis Sci 1980;19:328–331.
73.Leigh RJ, Thurston SE, Tomsak RL, et al: Effect of monocular visual loss upon stability of gaze. Invest Ophthalmol Vis Sci 1989;30:288–292.
74.Pritchard C, Flynn JT, Smith JL: Wave form characteristics of vertical oscillations in longstanding vision loss. J Pediatr Ophthalmol Strabismus 1988;25:233–236.
75.Barton JJ, Cox TA, Digre KB: Acquired convergence-evoked pendular nystagmus in multiple sclerosis. J Neuro-ophthalmol 1999;19:34–38.
76.Schwartz MA, Selhorst JB, Ochs AL, et al: Oculomasticatory myorhythmia: A unique movement disorder occurring in Whipple’s disease. Ann Neurol 1986;20:677–683.
77.Maas EF, Ashe J, Spiegel P, et al: Acquired pendular nystagmus in toluene addiction. Neurology 1991;41:282–285.
78.Nakada T, Kwee IL: Oculopalatal myoclonus. Brain 1986;109(pt 3):431–441.
79.Averbuch-Heller L, Tusa RJ, Fuhry L, et al: A double-blind controlled study of gabapentin and baclofen as treatment for acquired nystagmus. Ann Neurol 1997;41:818–825.
80.Starck M, Albrecht H, Pollmann W, et al: Drug therapy for acquired pendular nystagmus in multiple sclerosis. J Neurol 1997;244:9–16.
81.Shery T, Proudlock FA, Sarvananthan N, et al: The effects of gabapentin and memantine in acquired and congenital nystagmus—A retrospective study. Br J Ophthalmol 2006;90:839–843.
82.Ferro JM, Castro-Caldas A: Palatal myoclonus and carbamazepine. Ann Neurol 1981;10:402.
